Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
A novel small molecule targeting oncogenic PELP1 demonstrates anti-tumor activity in wild type and mutant estrogen receptor alpha-positive breast cancer
PubMed Full text in PMC Similar studies Analyze with GEO2R
Genome-wide copy number profiling of MCF-7 and fulvestrant-resistant MCF-7/FR cells by SNP microarray.
PubMed Full text in PMC Similar studies
Fulvestrant withdrawal from fulvestrant-resistant MCF-7/FR cells
RNA-seq of breast cancer cell lines post ligand treatment II
PubMed Similar studies Analyze with GEO2RSRA Run Selector
ATAC-seq, ChIP-seq and RNA-seq of breast cancer cell lines post ligand treatment
PubMed Similar studies
RNA-seq of breast cancer cell lines post ligand treatment I
ChIP-seq of ER in MCF-7 cells post ligand treatment
PubMed Similar studies SRA Run Selector
ATAC-seq of MCF-7 cells post ligand treatment
AKT antagonist AZD5363 influences estrogen receptor function in endocrine resistant breast cancer and synergizes with fulvestrant (ICI182780) in vivo
PubMed Similar studies Analyze with GEO2R
Effect of RBP2 on MCF7 breast cancer cells (RNA-seq)
Genome wide expression change by SMURF1 knocking down in MCF-7 cells
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor positive breast cancer
ER ChIP-seq of Androstenedione treated Letrozole Resistant Breast Cancer Cell line
Gene expression profiling of breast cancer cells with knockdown of PTEN
Synergistic targeting of estrogen-receptor positive breast cancers by MDM2 inhibition in combination with endocrine therapy or CDK4/6 inhibition
Heat Shock Factor 1 (HSF1) regulates ESR1 action in breast cancer
Heat Shock Factor 1 (HSF1) supports the ESR1 action in breast cancer
Heat Shock Factor 1 (HSF1) supports the ESR1 action in breast cancer (RNA-seq)
Heat Shock Factor 1 (HSF1) supports the ESR1 action in breast cancer (ChIP-seq)
PubMed Full text in PMC Similar studies SRA Run Selector
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on